David Shaw’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

David Shaw’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10,000	Closed	-$98K	–	6063
2021 Q4	$98K	Hold	10,000	–	–	﹤0.01%	5067
2021 Q3	$340K	Hold	10,000	–	–	﹤0.01%	4291
2021 Q2	$366K	Hold	10,000	–	–	﹤0.01%	4179
2021 Q1	$448K	Hold	10,000	–	–	﹤0.01%	3555
2020 Q4	$571K	Hold	10,000	–	–	﹤0.01%	3324
2020 Q3	$513K	Hold	10,000	–	–	﹤0.01%	3222
2020 Q2	$597K	Hold	10,000	–	–	﹤0.01%	3244
2020 Q1	$412K	Hold	10,000	–	–	﹤0.01%	3298
2019 Q4	$622K	Buy	+10,000	New	+$475K	﹤0.01%	3273

Other funds holding DCPH

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

David Shaw's DCPH Position: Q2 2024 in Review

David Shaw sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 506,384 shares — an estimated $7.97M sold.

David Shaw first reported a position in DCPH in Q2 2018 and held it in 16 quarters. The position peaked at $16.4M in Q4 2022. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

David Shaw reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
David Shaw sold 506,384 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $7.97M.
David Shaw first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 16 quarters.
David Shaw's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $16.4M in Q4 2022.
1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on D.E. Shaw & Co's 13F filing for Q2 2024, filed 14 Aug 2024.